Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
NASH: early-phase trial registry
4 of 11 indexed NASH trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 4 currently recruiting · #1,577 of 28,707 conditions by registered trial count
NASH: 11 US clinical trials tracked, 4 recruiting.
NASH is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Neuraly, running 1 of these trials.
Enrollment posture brief
Registry condition nash
OPEN 4 | RECR 36% | LATE 1 | EARLY 4 | RANK #1577 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (36% recruiting · 11 trials)
NASH lists 4 open slots (36% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for NASH on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
NASH is recruiting below its size-band peers.
4 of 11 indexed trials (36.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of NASH trials is spread across many organizations.
Neuraly accounts for 1 of 11 trials (9.1%). 11 distinct sponsors appear on at least one study for this condition label.
-
Typical NASH enrolment sits around 150 participants.
Median target enrolment is 150 among the 11 trials that report a genuine target (sentinel values excluded). 3 of those (27.3%) plan for fewer than 100 participants.
-
NASH splits between interventional and observational designs.
7 interventional and 4 observational studies make up this index (63.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
Foundation for the National Institutes of Health
NCT07122700
Androgens and NAFLD Longitudinal Cohort Study
University of California, San Francisco
NCT06124261
Digoxin In NASH (CODIN)
Yale University
NCT06588699
Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
Milton S. Hershey Medical Center
NCT06195943
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)
Madrigal Pharmaceuticals
NCT05500222
LITMUS Imaging Study
University of Oxford
NCT05479721
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
Kowa Research Institute
NCT05327127
A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH
Neuraly
NCT06410924
An Imaging-based Quantitative Biomarker Assay for NAFLD in Children
University of Wisconsin, Madison
NCT06354491
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT05669677
ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)
Aligos Therapeutics
NCT06342947
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 4 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on NASH records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on NASH trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this NASH page
11 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 NASH trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Neuraly sponsors the most NASH trials on record, review their full trial history before evaluating a specific study. See Neuraly's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This NASH condition card totals 11 registered trials; most-linked intervention Placebo; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.